Adding intravenous thrombolysis to endovascular treatment is not associated with an increased risk for bleeding or with changes in functional outcomes in patients with carotid tandem lesions.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

DiaMedica Therapeutics progresses DM199 for ischemic stroke and preeclampsia, aiming to expand treatment windows. Read why ...

Originally established in July 2023, the Mobile Stroke Treatment Unit was designed to expedite the process of giving care to people suffering from a stroke. The MSTU brings the hospital to the patient ...

The International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how ...

Modern medicine is a field of research that is constantly evolving, driving groundbreaking discoveries that have saved ...

In the Phase III EXPECTS trial, patients experiencing mostly mild posterior circulation ischemic stroke who were ineligible ...

While strokes affect people from all backgrounds, risks vary by race and ethnicity. The risk of having a first-time stroke is ...

USA: A new study published in Frontiers in Neurology highlights the potential of automatically quantified follow-up imaging ...

A researcher with a background in cancer and stroke, Ke Jian “Jim” Liu, Professor of Pathology and Associate Director or Basic Science at the Stony Brook Cancer Center who joined Stony Brook ...

Lucrecia Fernández Bordos, a 25-year-old resident of Capital Federal and a student of Advertising at the Universidad ...

SAN DIEGO -- Biomarker and cognitive data supported treatment with the anti-amyloid agent lecanemab (Leqembi) for up to 36 ...